InvestorsHub Logo
Followers 36
Posts 6105
Boards Moderated 0
Alias Born 01/28/2010

Re: KC01905 post# 5288

Monday, 05/20/2019 10:53:26 AM

Monday, May 20, 2019 10:53:26 AM

Post# of 6939
The purpose is to discuss submission for their drugs approval. This drug is a game changer. Thankfully the CEO is in step with the FDA and involved with them at a detail level. I'm looking for $35 pps after approval at buyout.